A detailed history of Widmann Financial Services, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Widmann Financial Services, Inc. holds 7,586 shares of BMY stock, worth $439,988. This represents 0.3% of its overall portfolio holdings.

Number of Shares
7,586
Previous 7,661 0.98%
Holding current value
$439,988
Previous $318,000 23.27%
% of portfolio
0.3%
Previous 0.26%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$39.66 - $51.75 $2,974 - $3,881
-75 Reduced 0.98%
7,586 $392,000
Q2 2024

Aug 14, 2024

SELL
$40.25 - $52.99 $8,855 - $11,657
-220 Reduced 2.79%
7,661 $318,000
Q1 2024

May 14, 2024

SELL
$47.98 - $54.4 $9,596 - $10,880
-200 Reduced 2.47%
7,881 $427,000
Q4 2023

Feb 13, 2024

SELL
$48.48 - $57.85 $50,176 - $59,874
-1,035 Reduced 11.35%
8,081 $414,000
Q3 2023

Nov 06, 2023

BUY
$57.89 - $64.73 $46,312 - $51,784
800 Added 9.62%
9,116 $529,000
Q1 2023

May 09, 2023

SELL
$65.71 - $74.53 $9,856 - $11,179
-150 Reduced 1.77%
8,316 $576,000
Q4 2022

Feb 06, 2023

SELL
$68.48 - $81.09 $1,780 - $2,108
-26 Reduced 0.31%
8,466 $609,000
Q3 2022

Nov 14, 2022

SELL
$0.13 - $76.84 $13 - $7,684
-100 Reduced 1.16%
8,492 $603,000
Q2 2022

Aug 01, 2022

SELL
$72.62 - $79.98 $8,714 - $9,597
-120 Reduced 1.38%
8,592 $661,000
Q1 2022

May 04, 2022

BUY
$61.48 - $73.72 $4,672 - $5,602
76 Added 0.88%
8,712 $636,000
Q4 2021

Jan 28, 2022

BUY
$53.63 - $62.52 $463,148 - $539,922
8,636 New
8,636 $538,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Widmann Financial Services, Inc. Portfolio

Follow Widmann Financial Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Widmann Financial Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Widmann Financial Services, Inc. with notifications on news.